The Biggest Problem in Biotech No One Talks About | Ep. 99 [Dr. Michael Weickert]

What does it really take to bring a life-saving medical breakthrough to patients? In this episode of Industry Ignited , Dr. Leeanne Aguilar sits down with Dr. Michael Weickert, CEO of Pacylex Pharmaceuticals and FE Pharmaceuticals, to discuss the realities of building first-in-class therapies in oncology and infectious disease. From the challenges of securing funding for breakthrough innovations to navigating clinical development and investor skepticism, Dr. Weickert shares decades of experience leading biotech companies focused on transforming patient care. The conversation explores the future of cancer treatment, groundbreaking approaches to combating antibiotic resistance, and why some of the most promising medical discoveries struggle to gain traction. Whether you're an entrepreneur, investor, healthcare professional, or simply curious about the future of medicine, this episode offers valuable insights into the science, strategy, and persistence required to bring revolutionary therapies to life. 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐠𝐧𝐢𝐭𝐞𝐝 https://industryignited.com/ 𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦 https://www.instagram.com/industryignited/ 𝐅𝐚𝐜𝐞𝐛𝐨𝐨𝐤 https://www.facebook.com/industryignited/ 𝐋𝐢𝐧𝐤𝐞𝐝𝐈𝐧 https://www.linkedin.com/company/industry-ignited 𝐒𝐩𝐨𝐭𝐢𝐟𝐲 https://open.spotify.com/show/3TX1L5LPr4lt1UtcSpSvlN?si=7037433a58c54162 𝐀𝐩𝐩𝐥𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 https://podcasts.apple.com/us/podcast/industry-ignited-podcast/id1824619671 𝐃𝐫. 𝐌𝐢𝐜𝐡𝐚𝐞𝐥 𝐖𝐞𝐢𝐜𝐤𝐞𝐫𝐭 https://www.linkedin.com/in/weickert/ https://www.linkedin.com/company/pacylex-pharma/ #podcast #podcastinterview #podcasts #podcastclips #podcastlife #industryignited #drleeanneaguilar #drmichaelweickert #biotechnology #innovation #healthcare